2Be Backer G, Ambrosioni E, Borch 1, et al. European guidelines oncardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical Practice (constit-uted by representatives of eight societies and by invited experts) [J]. Eur 1 Cardiovasc Prey Rehabil, 2003,10 (11) : 71-78.
3Li WC, Hsiao KY, Chen IC, et al. Serum leptin is associated with cardiome-tabolic risk and predicts metabolic syndrome in Taiwan Residents adults [J]. Cardiovasc Diabetol, 2011,10: 36.
4Khafaji HA, Bener AB, Rizk NM, et al. Elevated serum leptin levels in patients with acute myocardial infarction; correlation with coronary angiographic and echocardiographic finding [J]. BMC Res Notes, 2012,5: 262.
5Sierra 11, Romero-Corral A, Lopez-Jimenez F, et al.Relation of increased leptin concentrations to history of myocardial infarction and stroke in the United States population [J]. Am J Cardiol, 2007,100(2) :234-239.
6Ku lA, Farzaneh-Far R, Vittinghoff E, et al. Association of low leptin with cardiovascular events and mortlity inpatients with stable coronary artery disease : the Heart and Soul Study [J]. Atherosclerosis, 2011, 217 ( 2 ) : 503 -508 .
7Sattar N, Wannamethee G, Sarwar N, et al. Leptin and coronary heart disease: prospective study and systematic review [J]. Am Coli Cardiol, 2009,53(2) :167-175.
8Sattar N, Wannamethee G, Sarwar N, et al. Leptin and coronary heart disease: prospective study and systematic review [J]. Am Coli Cardiol, 2009,53(2): 167-175.
9Villarreal-Molina MT, Antuna-Puente B. Adiponect/n: anti-inflam- matory and cardioprotective effects[J]. Biochimie, 2012, 94 (10): 2143-2149.
10Shankar A, Marshall S, Li J. The association between plasma adipo- nectin level and hypertension[J]. Acta Cardiol, 2008, 63(2): 160- 165.
